These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 24422784)
1. Barriers and facilitators of hepatitis C screening among people who inject drugs: a multi-city, mixed-methods study. Barocas JA; Brennan MB; Hull SJ; Stokes S; Fangman JJ; Westergaard RP Harm Reduct J; 2014 Jan; 11():1. PubMed ID: 24422784 [TBL] [Abstract][Full Text] [Related]
2. Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: a qualitative study among people who inject drugs and service providers. Fontaine G; Presseau J; Bruneau J; Etherington C; Thomas IM; Hung JC; van Allen Z; Patey AM; Kareem A; Mortazhejri S; Høj SB; Boyer-Legault G; Grimshaw JM Int J Equity Health; 2024 Jun; 23(1):124. PubMed ID: 38886803 [TBL] [Abstract][Full Text] [Related]
3. Case-finding for hepatitis C in primary care: a mixed-methods service evaluation. Datta S; Horwood J; Hickman M; Sharp D Br J Gen Pract; 2014 Feb; 64(619):e67-74. PubMed ID: 24567619 [TBL] [Abstract][Full Text] [Related]
4. Barriers and facilitators of hepatitis C treatment uptake among people who inject drugs enrolled in opioid treatment programs in Baltimore. Falade-Nwulia O; Irvin R; Merkow A; Sulkowski M; Niculescu A; Olsen Y; Stoller K; Thomas DL; Latkin C; Mehta SH J Subst Abuse Treat; 2019 May; 100():45-51. PubMed ID: 30898327 [TBL] [Abstract][Full Text] [Related]
5. Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective. Crowley D; Van Hout MC; Lambert JS; Kelly E; Murphy C; Cullen W Harm Reduct J; 2018 Dec; 15(1):62. PubMed ID: 30538000 [TBL] [Abstract][Full Text] [Related]
6. The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia. Butler K; Day C; Dietze P; Bruno R; Alati R; Burns L J Subst Abuse Treat; 2015 Nov; 58():90-4. PubMed ID: 26117080 [TBL] [Abstract][Full Text] [Related]
7. Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities. Versfeld A; McBride A; Scheibe A; Spearman CW Harm Reduct J; 2020 Jun; 17(1):39. PubMed ID: 32522210 [TBL] [Abstract][Full Text] [Related]
8. Access to and use of health and social services among people who inject drugs in two urban areas of Mozambique, 2014: qualitative results from a formative assessment. Dengo-Baloi L; Boothe M; Semá Baltazar C; Sathane I; Langa DC; Condula M; Ricardo H; Inguane C; Teodoro E; Gouveia L; Raymond HF; Horth R BMC Public Health; 2020 Jun; 20(1):975. PubMed ID: 32571365 [TBL] [Abstract][Full Text] [Related]
9. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs. Bruggmann P; Grebely J Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939 [TBL] [Abstract][Full Text] [Related]
10. Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene. Gunn J; McNally S; Ryan J; Layton C; Bryant M; Walker S; O'Mahony C; Pedrana A Int J Drug Policy; 2021 Oct; 96():103387. PubMed ID: 34330571 [TBL] [Abstract][Full Text] [Related]
11. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia. Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084 [TBL] [Abstract][Full Text] [Related]
12. Internalized stigma and sterile syringe use among people who inject drugs in New York City, 2010-2012. Rivera AV; DeCuir J; Crawford ND; Amesty S; Lewis CF Drug Alcohol Depend; 2014 Nov; 144():259-64. PubMed ID: 25307745 [TBL] [Abstract][Full Text] [Related]
13. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose. Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700 [TBL] [Abstract][Full Text] [Related]
15. Computerized Tailored Interventions to Enhance Prevention and Screening for Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Randomized Pilot Study. Westergaard RP; Hull SJ; Merkow A; Stephens LK; Hochstatter KR; Olson-Streed HK; Baker LM; Hess TM JMIR Res Protoc; 2016 Jan; 5(1):e15. PubMed ID: 26800903 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. Harris M; Rhodes T Harm Reduct J; 2013 May; 10():7. PubMed ID: 23651646 [TBL] [Abstract][Full Text] [Related]
17. Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study. Marshall AD; Rance J; Dore GJ; Grebely J; Treloar C Int J Drug Policy; 2024 Jul; 129():104477. PubMed ID: 38861842 [TBL] [Abstract][Full Text] [Related]
18. Attitudes towards people living with HIV and people who inject drugs: A mixed method study of stigmas within harm reduction programs in Kazakhstan. Stringer KL; Mukherjee T; McCrimmon T; Terlikbayeva A; Primbetovac S; Darisheva M; Hunt T; Gilbert L; El-Bassel N Int J Drug Policy; 2019 Jun; 68():27-36. PubMed ID: 30981165 [TBL] [Abstract][Full Text] [Related]
19. "They look at us like junkies": influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Muncan B; Walters SM; Ezell J; Ompad DC Harm Reduct J; 2020 Jul; 17(1):53. PubMed ID: 32736624 [TBL] [Abstract][Full Text] [Related]
20. Promoting Safe Injection Practices, Substance Use Reduction, Hepatitis C Testing, and Overdose Prevention Among Syringe Service Program Clients Using a Computer-Tailored Intervention: Pilot Randomized Controlled Trial. Hochstatter KR; Hull SJ; Sethi AK; Burns ME; Mundt MP; Westergaard RP J Med Internet Res; 2020 Sep; 22(9):e19703. PubMed ID: 32990630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]